These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 101143)

  • 21. Antiactivator in plasma of patients with Behçet's disease.
    Tsushima H; Toki N
    J Dermatol; 1981 Oct; 8(5):379-83. PubMed ID: 6173406
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
    Verheijen JH; Chang GT; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):392-5. PubMed ID: 6437006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.
    Einarsson M; Brandt J; Kaplan L
    Biochim Biophys Acta; 1985 Jul; 830(1):1-10. PubMed ID: 4040396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation of plasminogen activators from human uterine tissue and a comparison with activators from human urine and porcine tissue.
    Kok P
    Thromb Haemost; 1979 Jun; 41(4):718-33. PubMed ID: 113901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in plasma tissue plasminogen activator and plasminogen activator inhibitor in acute myocardial infarction and its clinical significance].
    Jia HY; Chen HZ; Pu SY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Aug; 16(4):214-6, 254. PubMed ID: 3147887
    [No Abstract]   [Full Text] [Related]  

  • 27. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
    Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
    Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation.
    Virji MA; Aggarwal S; Kang Y
    Transplant Proc; 1989 Jun; 21(3):3540-1. PubMed ID: 2500760
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.
    Kirchheimer J; Köller A; Binder BR
    Biochim Biophys Acta; 1984 Feb; 797(2):256-65. PubMed ID: 6199043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED; Akkerman JW; Jansen BG
    Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Obtaining active plasminogen from the blood plasma of those who have died suddenly].
    Petrenko OA; Khvatov VB
    Probl Gematol Pereliv Krovi; 1976 Dec; 21(12):46-8. PubMed ID: 1024207
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.
    Colucci M; Paramo JA; Collen D
    J Lab Clin Med; 1986 Jul; 108(1):53-9. PubMed ID: 3086473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 35. Separation of plasminogen activators from human plasma and a comparison with activators from human uterine tissue and urine.
    Kok P
    Thromb Haemost; 1979 Jun; 41(4):734-44. PubMed ID: 483246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fibrinolytic system in pre-eclampsia.
    Gow L; Campbell DM; Ogston D
    J Clin Pathol; 1984 Jan; 37(1):56-8. PubMed ID: 6423699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma determination of plasminogen activator inhibitor 1 antigen must be performed in blood collected on antiplatelet/anticoagulant mixture.
    Juhan-Vague I; Alessi MC; Fossat C; Declerck PJ; Kruithof EK
    Thromb Haemost; 1987 Dec; 58(4):1096. PubMed ID: 3127921
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Distinction of plasma inhibitor of activator-induced clot lysis from antiplasmins.
    Aoki N; Matsuda M; Moroi M; Yoshida N
    Thromb Diath Haemorrh; 1975 Sep; 34(1):350. PubMed ID: 127401
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanisms of inhibition of tissue-type plasminogen activator in blood.
    Collen D
    Thromb Haemost; 1983 Oct; 50(3):678. PubMed ID: 6417816
    [No Abstract]   [Full Text] [Related]  

  • 40. The human gene for plasminogen activator inhibitor 2 (PAI2) exhibits an EcoRI RFLP.
    van den Berg EA; le Clercq E; Kooistra T; Frants RR; Bakker E
    Nucleic Acids Res; 1990 May; 18(9):2837. PubMed ID: 1971103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.